• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Hollister

    Hollister
    hollister

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Denis Blais, Canada

    Denis Blais, Canada

  • Hans Dieter Olszewski, Germany

    Hans Dieter Olszewski, Germany

  • Mike Cels, Canada

    Mike Cels, Canada

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Daniela Maria Daverio, Argentina

    Daniela Maria Daverio, Argentina

  • Dick Dayton, USA

    Dick Dayton, USA

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Chris McCauley, Canada

    Chris McCauley, Canada

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • John Dinon, Australia

    John Dinon, Australia

  • Inta Grubb, Australia

    Inta Grubb, Australia

  • Marcelo Farinelli, Brazil

    Marcelo Farinelli, Brazil

  • David Bishop, UK

    David Bishop, UK

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Debbie Craghill, USA

    Debbie Craghill, USA

  • Jon Newsome, USA

    Jon Newsome, USA

  • Barry de Reuver, Netherlands

    Barry de Reuver, Netherlands

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • David Watson, Scotland

    David Watson, Scotland

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Ana María Zavala, Mexico

    Ana María Zavala, Mexico

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Alex, Argentina

    Alex, Argentina

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Purningam Jacob, India

    Purningam Jacob, India

  • Mirca Bersani, Italy

    Mirca Bersani, Italy
    MircaBersani

  • Glen Elison, USA

    Glen Elison, USA

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login